AstraZeneca
AZN
#70
Rank
โ‚ฌ219.60 B
Marketcap
141,60ย โ‚ฌ
Share price
-0.84%
Change (1 day)
-4.83%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: โ‚ฌ219.60 Billion

As of October 2026 AstraZeneca has a market cap of โ‚ฌ219.60 Billion. This makes AstraZeneca the world's 70th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ219.60 B-10.39%
2025โ‚ฌ245.05 B25.25%
2024โ‚ฌ195.66 B3.4%
2023โ‚ฌ189.22 B-3.52%
2022โ‚ฌ196.13 B22.4%
2021โ‚ฌ160.23 B50.46%
2020โ‚ฌ106.49 B-8.84%
2019โ‚ฌ116.82 B41.54%
2018โ‚ฌ82.53 B13.67%
2017โ‚ฌ72.61 B10.75%
2016โ‚ฌ65.56 B-17.08%
2015โ‚ฌ79.07 B7.38%
2014โ‚ฌ73.64 B37.24%
2013โ‚ฌ53.65 B21.08%
2012โ‚ฌ44.31 B-4.92%
2011โ‚ฌ46.60 B-4.74%
2010โ‚ฌ48.92 B2.93%
2009โ‚ฌ47.53 B11.9%
2008โ‚ฌ42.48 B-0.58%
2007โ‚ฌ42.72 B-31.27%
2006โ‚ฌ62.17 B-5.64%
2005โ‚ฌ65.88 B49.4%
2004โ‚ฌ44.10 B-32.21%
2003โ‚ฌ65.05 B12.77%
2002โ‚ฌ57.69 B-37.35%
2001โ‚ฌ92.09 B-4.61%
2000โ‚ฌ96.54 B31.02%
1999โ‚ฌ73.68 B105.13%
1998โ‚ฌ35.92 B24.76%
1997โ‚ฌ28.79 B28.82%
1996โ‚ฌ22.35 B

End of Day market cap according to different sources

On Oct 8th, 2026 the market cap of AstraZeneca was reported to be:

โ‚ฌ219.41 Billion
by Nasdaq info icon info icon
โ‚ฌ219.60 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ551.21 B 151.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ242.57 B 10.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ141.40 B-35.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ152.98 B-30.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ929.72 B 323.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ85.96 B-60.85%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ28.78 B-86.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ313.26 B 42.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ108.53 B-50.58%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ83.15 B-62.14%๐Ÿ‡ฌ๐Ÿ‡ง UK